# Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome

> **NCT00003601** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 38 (estimated)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **DRUG:** fenretinide
- **DRUG:** tretinoin

## Key facts

- **NCT ID:** NCT00003601
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02-23
- **Primary completion:** 2000-03
- **Final completion:** 2004-03-02
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003601, "Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*